Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base

被引：0
|
作者：
Amy C. Moreno
Waqar Haque
Vivek Verma
Penny Fang
Steven H. Lin
机构：
[1] University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[2] Houston Methodist Hospital,Department of Radiation Oncology
[3] University of Nebraska Medical Center,Department of Radiation Oncology
来源：
Annals of Surgical Oncology | 2018年 / 25卷
关键词：
National Cancer Data Base (NCDB); Propensity Matching; Non-small Cell Lung Cancer (NSCLC); Relative Toxicity Factor; Indication Bias;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1245 / 1253
页数：8
相关论文
共 50 条
  • [31] Prognostic Factors in Patients with Resected Pathological N2 Non-Small Cell Lung Cancer
    Goto, T.
    Nakamura, M.
    Shimizu, Y.
    Sato, S.
    Koike, T.
    Tsuchida, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S879 - S879
  • [32] Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer
    Cho, Hyun Jin
    Kim, Sung Ryong
    Kim, Hyeong Ryul
    Han, Jin-Ok
    Kim, Yong-Hee
    Kim, Dong Kwan
    Park, Seung-Il
    ANNALS OF THORACIC SURGERY, 2014, 97 (06): : 1920 - 1925
  • [33] The Role of Postoperative Radiation Therapy in pN2 Non-Small Cell Lung Cancer: An Analysis of the National Cancer Data Base
    Herskovic, A.
    Christos, P.
    Mauer, E.
    Nagar, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S69 - S69
  • [34] MANAGEMENT OF N2 NON-SMALL CELL LUNG CANCER
    Shetty, Preethi S.
    Mankar, Hemant
    Pramesh, C. S.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (05): : 1463 - 1464
  • [35] To Evaluate the Efficacy and Optimal Timing of Postoperative Radiotherapy in Completely Resected stage IIIA(N2) Non-Small Cell Lung Cancer
    Feng, W.
    Fu, X.
    Cai, X.
    Liu, J.
    Hu, D.
    Xu, Y.
    Zhu, Z.
    Zhao, S.
    Bai, Y.
    He, J.
    Chen, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S360 - S361
  • [36] Risk factors of brain metastases as initial failure in completely resected stage IIIA(N2) non-small cell lung cancer
    Zhang, Qin
    Cai, Xu-Wei
    Feng, Wen
    Yu, Wen
    Fu, Xiao-Long
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [37] Risk Factors of Brain Metastases as Initial Failure for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer
    Zhang, Q.
    Fu, X.
    Feng, W.
    Cai, X. W.
    Yu, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E398 - E399
  • [38] Clinical Impact of the Tumor Immune Microenvironment and Immunoscore in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer
    Feng, W.
    Fu, X.
    Cai, X.
    Zhang, Q.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1872 - S1872
  • [39] Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer
    Xu, Yujin
    Li, Jianqiang
    Wang, Jin
    Hu, Xiao
    Ma, Honglian
    Li, Pu
    Zheng, Xiao
    Chen, Ming
    ONCOLOGY LETTERS, 2018, 15 (02) : 2641 - 2650
  • [40] Upfront Surgery Versus Neoadjuvant Treatment Followed by Surgery in Pathologic N2 Non-Small Cell Lung Cancer
    Kim, S. K.
    Park, H. S.
    Cho, K. D.
    Cho, D. G.
    Park, Y. H.
    Yoo, J.
    Kim, S. H.
    Ko, J. M.
    Park, E. J.
    Heo, G. R.
    Kim, C. H.
    Shim, B. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S900 - S901
12345